Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans A Grifoni, J Pham, J Sidney, PH O'Rourke, S Paul, B Peters, SR Martini, ... Journal of virology 91 (24), 10.1128/jvi. 01469-17, 2017 | 183 | 2017 |
Global Assessment of Dengue Virus-Specific CD4+ T Cell Responses in Dengue-Endemic Areas A Grifoni, MA Angelo, B Lopez, PH O’Rourke, J Sidney, C Cerpas, ... Frontiers in immunology 8, 1309, 2017 | 81 | 2017 |
Predictors of mortality in patients with yellow fever: an observational cohort study EG Kallas, LGFABDE Zanella, CHV Moreira, R Buccheri, GBF Diniz, ... The Lancet infectious diseases 19 (7), 750-758, 2019 | 76 | 2019 |
Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial EG Kallas, AR Precioso, R Palacios, B Thomé, PE Braga, T Vanni, ... The Lancet Infectious Diseases 20 (7), 839-850, 2020 | 59 | 2020 |
MAIT cells are activated in acute Dengue virus infection and after in vitro Zika virus infection D Paquin-Proulx, VI Avelino-Silva, BAN Santos, N Silveira Barsotti, ... PLoS neglected tropical diseases 12 (1), e0006154, 2018 | 49 | 2018 |
Aspectos do escorpionismo no Estado do Pará-Brasil A Maestri Neto, AB Guedes, SF Carmo, HM Chalkidis, J Souza Coelho, ... Revista Paraense de Medicina 22 (1), 49-55, 2008 | 26 | 2008 |
A human inferred germline antibody binds to an immunodominant epitope and neutralizes Zika virus DM Magnani, CGT Silveira, BC Rosen, MJ Ricciardi, N Pedreño-Lopez, ... PLoS neglected tropical diseases 11 (6), e0005655, 2017 | 20 | 2017 |
T-cell responses in individuals infected with Zika virus and in those vaccinated against dengue virus D Paquin-Proulx, FE Leal, CGT Silveira, A Maestri, C Brockmeyer, ... Pathogens & immunity 2 (2), 274, 2017 | 19 | 2017 |
Persistence of rabies virus-neutralizing antibodies after vaccination of rural population following vampire bat rabies outbreak in Brazil R Medeiros, V Jusot, G Houillon, A Rasuli, L Martorelli, AP Kataoka, ... PLoS Neglected Tropical Diseases 10 (9), e0004920, 2016 | 19 | 2016 |
Robust and functional immune memory up to 9 months after SARS-CoV-2 infection: a Southeast Asian longitudinal cohort HTM Vo, A Maestri, H Auerswald, S Sorn, S Lay, H Seng, S Sann, N Ya, ... Frontiers in Immunology 13, 817905, 2022 | 17 | 2022 |
The CCR5Δ32 (rs333) polymorphism is not a predisposing factor for severe pandemic influenza in the Brazilian admixed population A Maestri, MC Dos Santos, EM Ribeiro-Rodrigues, WA De Mello, ... BMC research notes 8, 1-5, 2015 | 17 | 2015 |
Siaα2-3Galβ1- Receptor Genetic Variants Are Associated with Influenza A(H1N1)pdm09 Severity A Maestri, VA Sortica, L Tovo-Rodrigues, MC Santos, L Barbagelata, ... PloS one 10 (10), e0139681, 2015 | 17 | 2015 |
Dissecting drivers of immune activation in chronic HIV-1 infection H Streeck, A Maestri, D Habermann, TA Crowell, AL Esber, G Son, ... Ebiomedicine 83, 2022 | 9 | 2022 |
Neurological manifestations in people living with HIV/AIDS in the late cART era: a prospective observational study at a tertiary healthcare center in São Paulo, Brazil JP Telles, R Fernandes, TD Barros, A Maestri, T Vitoriano, L Borges, ... HIV Research & Clinical Practice 22 (4), 87-95, 2021 | 9 | 2021 |
Global assessment of dengue virus-specific CD4 (+) T cell responses in dengue-endemic areas. Front Immunol 8: 1309 A Grifoni, MA Angelo, B Lopez, PH O’Rourke, J Sidney, C Cerpas, ... | 7 | 2017 |
Viral kinetics in sylvatic yellow fever cases VI Avelino-Silva, MV Thomazella, MP Marmorato, CA Correia, JZC Dias, ... The Journal of Infectious Diseases 227 (9), 1097-1103, 2023 | 5 | 2023 |
The His131Arg substitution in the FCGR2A gene (rs1801274) is not associated with the severity of influenza A (H1N1) pdm09 infection A Maestri, VA Sortica, DL Ferreira, J de Almeida Ferreira, MAT Amador, ... BMC Research Notes 9, 1-4, 2016 | 5 | 2016 |
Levels of angiopoietin-2 are predictive for mortality in yellow fever virus infected patients. CAM van de Weg, MV Thomazella, MP Marmorato, CA Correia, JZC Dias, ... The Journal of Infectious Diseases, jiad389-jiad389, 2023 | 1 | 2023 |
A phase 3, single-arm, open-label study to evaluate the safety, tolerability, and immunogenicity of a 15-valent pneumococcal conjugate vaccine, V114, in a 3+ 1 regimen in … A Maestri, SE Park, F Fernandes, ZL Li, YJ Kim, YK Kim, J Lee, JY Park, ... Human Vaccines & Immunotherapeutics 20 (1), 2321035, 2024 | | 2024 |
Levels of Angiopoietin 2 Are Predictive for Mortality in Patients Infected With Yellow Fever Virus CAM van de Weg, MV Thomazella, MP Marmorato, CA Correia, JZC Dias, ... The Journal of Infectious Diseases, jiad389, 2023 | | 2023 |